Key Points
Atrial fibrillation is a co‐morbidity for PCI patients that may complicate risk‐benefit decisions for antithrombotic therapy.
Recently developed PRECISE‐DAPT score may be useful in judging the bleeding risk of atrial fibrillation patients undergoing PCI.
Optimal tools to understand bleeding risk from both pharmacologic and device choices continue to be a need in the PCI population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.